Pulse Biosciences, Inc.
PLSE
$25.57
$1.204.90%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 51.89% | 206.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 51.89% | 206.98% | |||
| Cost of Revenue | 42.31% | -6.81% | |||
| Gross Profit | 675.00% | 102.07% | |||
| SG&A Expenses | -10.08% | -16.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.58% | -9.47% | |||
| Operating Income | -4.91% | 10.38% | |||
| Income Before Tax | -6.59% | 10.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.59% | 10.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.59% | 10.07% | |||
| EBIT | -4.91% | 10.38% | |||
| EBITDA | -5.01% | 10.53% | |||
| EPS Basic | -6.26% | 10.60% | |||
| Normalized Basic EPS | -6.29% | 10.62% | |||
| EPS Diluted | -6.26% | 10.60% | |||
| Normalized Diluted EPS | -6.29% | 10.62% | |||
| Average Basic Shares Outstanding | 0.30% | 0.60% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||